United Therapeutics Corp (UTHR)
366.97
+2.64
(+0.72%)
USD |
NASDAQ |
Nov 21, 16:00
367.86
+0.89
(+0.24%)
After-Hours: 19:48
United Therapeutics Price to Book Value: 2.685 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.666 |
| November 19, 2024 | 2.640 |
| November 18, 2024 | 2.629 |
| November 15, 2024 | 2.658 |
| November 14, 2024 | 2.827 |
| November 13, 2024 | 2.930 |
| November 12, 2024 | 2.933 |
| November 11, 2024 | 2.930 |
| November 08, 2024 | 3.000 |
| November 07, 2024 | 2.946 |
| November 06, 2024 | 2.909 |
| November 05, 2024 | 2.801 |
| November 04, 2024 | 2.757 |
| November 01, 2024 | 2.737 |
| October 31, 2024 | 2.737 |
| October 30, 2024 | 2.645 |
| October 29, 2024 | 2.582 |
| October 28, 2024 | 2.559 |
| October 25, 2024 | 2.551 |
| October 24, 2024 | 2.563 |
| October 23, 2024 | 2.580 |
| October 22, 2024 | 2.708 |
| October 21, 2024 | 2.710 |
| October 18, 2024 | 2.694 |
| October 17, 2024 | 2.726 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.706 |
| October 15, 2024 | 2.630 |
| October 14, 2024 | 2.612 |
| October 11, 2024 | 2.620 |
| October 10, 2024 | 2.591 |
| October 09, 2024 | 2.609 |
| October 08, 2024 | 2.602 |
| October 07, 2024 | 2.558 |
| October 04, 2024 | 2.603 |
| October 03, 2024 | 2.560 |
| October 02, 2024 | 2.578 |
| October 01, 2024 | 2.617 |
| September 30, 2024 | 2.621 |
| September 27, 2024 | 2.800 |
| September 26, 2024 | 2.794 |
| September 25, 2024 | 2.808 |
| September 24, 2024 | 2.795 |
| September 23, 2024 | 2.777 |
| September 20, 2024 | 2.757 |
| September 19, 2024 | 2.744 |
| September 18, 2024 | 2.675 |
| September 17, 2024 | 2.694 |
| September 16, 2024 | 2.694 |
| September 13, 2024 | 2.648 |
| September 12, 2024 | 2.664 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.253
Minimum
Mar 18 2020
3.000
Maximum
Nov 08 2024
2.114
Average
2.119
Median
Price to Book Value Benchmarks
| Liquidia Corp | 7.781 |
| Pfizer Inc | 1.543 |
| Tonix Pharmaceuticals Holding Corp | 0.5075 |
| Ardelyx Inc | 7.653 |
| Cingulate Inc | 1.236 |
Price to Book Value Related Metrics
| PE Ratio | 16.12 |
| PS Ratio | 6.511 |
| PEG Ratio | 0.6332 |
| Price to Free Cash Flow | 19.98 |
| Price | 366.97 |
| Earnings Yield | 6.20% |
| Market Cap | 16.38B |
| PEGY Ratio | 0.6332 |
| Operating PE Ratio | 13.35 |
| Normalized PE Ratio | 15.39 |